Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

13

Dec 2019

Equillium & Biocon Expand Exclusive Licensing Agreement for Itolizumab to Include Australia and New Zealand

Equillium Inc a clinicalstage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders and Biocon Ltd an innovationled global biopharmaceuticals company today announced that they have expanded their collaboration a...

13

Dec 2019

Iktos and Almirall Announce Research Collaboration in Artificial Intelligence for New Drug Design

Iktos a company specialized in Artificial Intelligence for novel drug design and Almirall SA ALM a leading skinhealth focused global pharmaceutical company today announced a collaboration agreement in Artificial Intelligence AI where Iktos generative modelling technology will be used to design novel...

12

Dec 2019

Forendo Pharma Signs Important License and Collaboration Deal with Leading Pharma Company

Forendo Pharma a clinical stage drug development company focusing on novel treatments in womens health today announces signing of a License and Collaboration Agreement with Novartis The joint research collaboration is aimed at the identification of novel drugs for the treatment of chronic liver dise...

12

Dec 2019

NeoImmuneTech Announces Clinical Collaboration to Evaluate Hyleukin-7™ (NT-I7)

NeoImmuneTech Inc a clinicalstage T cellfocused biopharmaceutical company announced today it has entered into a clinical collaboration agreement with Merck known as MSD outside of the United States and Canada through a subsidiary to evaluate the combination of NeoImmuneTechs Hyleukin NTI and Mercks...

11

Dec 2019

Bloom Science Collaborates with Cedars-Sinai Medical Center to Expand Microbiome Research and Discovery into Brain Cancer

Bloom Science a biopharmaceutical company developing microbiomederived therapeutics in multiple neurological conditions and oncology today announced the launch of a research agreement with CedarsSinai Medical Center The collaboration will focus on advancing the understanding of the microbiome in a P...

11

Dec 2019

Engitix and Morphic Enter Research Collaboration to Identify ECM-Related Targets in Fibrostenotic Inflammatory Bowel Disease (IBD)

Engitix Ltd Engitix a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix ECM platform and Morphic Therapeutic Morphic a biopharmaceutical company developing oral integrin therapies today announce that they have en...

10

Dec 2019

Samyang Biopharm USA, Inc. and Talix Therapeutics NV Announce Global Strategic Collaboration to Advance Novel Immuno-Oncology Therapeutic

Samyang Biopharm USA Inc a global biotech subsidiary of the Samyang Pharmaceuticals Corp announced today that the company has entered into a research collaboration with the exclusive option to a worldwide licensing agreement with Talix Therapeutics NV Financial terms of the agreement were not disclo...

10

Dec 2019

Gemini Therapeutics and Avitide Enter Into Exclusive License Agreement

Avitide Inc the industry leader in the discovery and development of custom affinity purification resins announces that it has entered into an exclusive license agreement to support the development of one of Gemini Therapeutics therapeutic programs

09

Dec 2019

Janssen to Acquire Investigational Bermekimab from XBiotech

Janssen Biotech Inc a Janssen Pharmaceutical Company of Johnson Johnson announced today that it has entered a definitive agreement to acquire all rights to the investigational compound bermekimab from XBiotech Inc Bermekimab is an antiILalpha monoclonal antibody mAb in Phase development for the tr...

press releasesRead more...

13

Dec 2019

FDA grants accelerated approval to first targeted treatment for rare Duchenne muscular dystrophy mutation

The US Food and Drug Administration today granted accelerated approval to Vyondys golodirsen injection to treat Duchenne muscular dystrophy DMD patients who have a confirmed mutation of the dystrophin gene that is amenable to exon skipping It is estimated that about percent of patients with DMD h...

13

Dec 2019

FDA Approves XELJANZ® XR (tofacitinib) Extended-Release Tablets for the Treatment of Ulcerative Colitis

Pfizer Inc announced today that the US Food and Drug Administration FDA has approved XELJANZ XR tofacitinib extendedrelease mg and mg tablets for the oncedaily treatment of adult patients with moderately to severely active ulcerative colitis UC after an inadequate response or intolerance to TNF bl...

12

Dec 2019

ZETA Engineering for LONZA's mega project IbexTM Solutions

ZETA is providing the detailed layout for the singleuse plant in which upstream midstream and downstream processes are integrated in a single module The complex multipurpose plant is designed for the utmost flexibility to map a wide range of processes at different scales

12

Dec 2019

MIHAS 2020 To Promote The Values Of Sustainability Among Halal-based Businesses

Worlds largest halal trade fair the Malaysia International Halal Showcase MIHAS is set to host Malaysian and global Halalbased businesses at its th edition from to April In this edition MIHAS will be facilitating the promotion of sustainability practices among Halalbased industry players

12

Dec 2019

Kite and Kiniksa Pharmaceuticals Announce Clinical Collaboration

Kite a Gilead Company and Kiniksa Pharmaceuticals Ltd announced today that the companies have entered into a clinical collaboration to conduct a Phase multicenter study of mavrilimumab an investigational fully human monoclonal antibody that targets granulocyte macrophage colony stimulating factor r...

12

Dec 2019

Novartis announces FDA filing acceptance of Xolair® (omalizumab) for treatment of nasal polyps

Novartis today announced that the US Food and Drug Administration FDA has accepted the companys supplemental Biologics License Application sBLA for Xolair omalizumab for the treatment of nasal polyps in adult patients years of age and older with inadequate response to intranasal corticosteroids If...

11

Dec 2019

Zealand Pharma partner Beta Bionics receives FDA Breakthrough Device Designation for the iLet™ Bionic Pancreas System

Zealand Pharma AS a Copenhagenbased biotechnology company focused on the discovery and development of innovative peptidebased medicines announces that partner Beta Bionics Inc has received Breakthrough Device designation from the US Food and Drug Administration FDA for its iLet Bionic Pancreas Syst...

11

Dec 2019

Dermira Receives Fast Track Designation from FDA for Lebrikizumab for the Treatment of Atopic Dermatitis

Dermira Inc a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated new therapies to the millions of patients living with chronic skin conditions today announced that the US Food and Drug Administration FDA has granted Fast Track design...

10

Dec 2019

Vetter's occupational health management excels again in employee wellness initiatives

According to studies an evergreater number of staff members are complaining about increasing mental stress Nevertheless according to a recent survey among staff members commissioned by LinkedIn percent of employers do not offer any preventive actions for stress symptoms such as tension or sleep dis...

EventsRead more...

28 - 29

Dec 2019

Nursing Care and Patient Safety

GSE Academy
The President Hotel Cape Town

13 - 15

Jan 2020

Biotech Showcase 2020

EBD Group / Demy-Colton
Hilton San Francisco Union Square

15 - 17

Jan 2020

Otorhinolaryngology Audiology

InterContinental Dubai Festival City

20 - 21

Jan 2020

Disruptive Technologies In Pharma 2020

Holiday Inn Kensington Forum

20 - 21

Jan 2020

Annual Pharmaceutical Microbiology Conference

SMi Group
Copthorne Tara Hotel London Kensington

20 - 21

Jan 2020

Pharma Industry and Pharmaceuticals

Conference Series LLC LTD
Hong Kong

21 - 23

Jan 2020

9th Trial Master File Summit

ExL Events
Sheraton Orlando Lake Buena Vista Resort

21 - 23

Jan 2020

9th CROWN Congress

ExL Events
Sheraton Orlando Lake Buena Vista Resort

23 - 24

Jan 2020

Advertisements

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    Merck

    Staff Engineer, Manufacturing Science and Technology, South East Asia

    Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot...
  • Articles

    A Concise Treatise on Hard and Soft Nanomaterials for Drug Delivery

    Most of the conventional free drugs suffer from high side effects poor adsorption poor solubility high drug dosing minimum efficiency uncontrolled and nonspecific delivery with high cytotoxicity which limit their uses With respect to the chemotherapeutic drugs concern is more because most of the anticancer drugs are highly toxic for the healthy cells and damage the he...

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...